In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria—albumin in urine, a sign of kidney damage—for 50% of participants. When the experimental drug was paired ...
Dec 15, 2023
0
104
Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute ...
Dec 14, 2023
0
32
Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, have found that statins, the most prescribed class of drugs to treat high cholesterol, reduced the risk of heart ...
Dec 6, 2023
0
96
3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionize the monitoring of kidney disease, which often progresses without ...
Dec 5, 2023
0
83
When a patient with chronic kidney disease finally reaches the point that their kidneys fail, doctors have a treatment available: dialysis. But undergoing dialysis often brings a high burden of other unpleasant symptoms—fatigue, ...
Jun 20, 2023
0
26
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose hemodiafiltration compared to those treated with high flux hemodialysis, according to new research from the CONVINCE ...
Jun 16, 2023
0
78
Fresh insights into a protein that causes damage in kidneys and hearts could open up new treatment options for chronic kidney disease, research shows.
May 31, 2023
0
58
About 3 million Americans live with cardiovascular implantable electronic devices—commonly known as pacemakers. These small electronic devices implanted in the chest or abdomen are typically used to treat slow or irregular ...
May 23, 2023
0
19
The prevalence of multimorbidity, the co-occurrence of two or more chronic conditions, varies depending on exactly how it is defined. And the health care costs associated with many disease combinations cost more together ...
Apr 4, 2023
0
20
The latest findings from the PROTECT phase III trial show sparsentan—a novel treatment for IgA nephropathy—significantly reduces proteinuria, or abnormal protein levels in the urine, compared to standard treatment irbesartan.
Apr 3, 2023
0
78
